Europe - BIT:1BSX - US1011371077 - Common Stock
We assign a fundamental rating of 5 out of 10 to 1BSX. 1BSX was compared to 62 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of 1BSX get a neutral evaluation. Nothing too spectacular is happening here. 1BSX is valued quite expensively, but it does show have an excellent growth rating. This makes 1BSX very considerable for growth investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.03% | ||
| ROE | 11.17% | ||
| ROIC | 7.66% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.69% | ||
| PM (TTM) | 13.54% | ||
| GM | 68.3% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 3.33 | ||
| Altman-Z | 5.39 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.82 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.45 | ||
| Fwd PE | 29.2 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 42.63 | ||
| EV/EBITDA | 32.2 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1BSX (10/20/2025, 7:00:00 PM)
85.8
+2.8 (+3.37%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 35.45 | ||
| Fwd PE | 29.2 | ||
| P/S | 8.03 | ||
| P/FCF | 42.63 | ||
| P/OCF | 34.67 | ||
| P/B | 6.62 | ||
| P/tB | N/A | ||
| EV/EBITDA | 32.2 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.03% | ||
| ROE | 11.17% | ||
| ROCE | 9.51% | ||
| ROIC | 7.66% | ||
| ROICexc | 7.77% | ||
| ROICexgc | 26.52% | ||
| OM | 18.69% | ||
| PM (TTM) | 13.54% | ||
| GM | 68.3% | ||
| FCFM | 18.84% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 3.33 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 60.84% | ||
| Cap/Sales | 4.33% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 89.77% | ||
| Profit Quality | 139.08% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 0.82 | ||
| Altman-Z | 5.39 |
ChartMill assigns a fundamental rating of 5 / 10 to 1BSX.MI.
ChartMill assigns a valuation rating of 3 / 10 to BOSTON SCIENTIFIC CORP (1BSX.MI). This can be considered as Overvalued.
BOSTON SCIENTIFIC CORP (1BSX.MI) has a profitability rating of 6 / 10.
The Price/Earnings (PE) ratio for BOSTON SCIENTIFIC CORP (1BSX.MI) is 35.45 and the Price/Book (PB) ratio is 6.62.
The financial health rating of BOSTON SCIENTIFIC CORP (1BSX.MI) is 5 / 10.